Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 22, 2017

View Archived Issues

ICEC-0942 reduces tumor growth in preclinical models of breast cancer

Researchers develop a novel Crbn-mutant multiple myeloma mouse model

MAP1B gene found to be associated with periventricular nodular heterotopia

Phase II data presented for mAb hu3S193 in breast cancer patients

First patient treated in phase I study of Achillion's ACH-5228

European Commission approves Alecensa as first-line treatment in ALK-positive NSCLC

Frequency Therapeutics completes first-in-human study of drug candidate for hearing loss

Denali Therapeutics gives update on LRRK2 inhibitor programs

Arvinas selects second drug candidate

Jazz Pharmaceuticals submits NDA in U.S. for solriamfetol

First healthy subjects dosed in phase I trial of PRS-060

FDA issues complete response letter for Santen's NDA for intravitreal sirolimus

Spanish researchers patent RyR1 modulators

Novo Nordisk divulges new GDF-15 compounds

University of Patras presents geminin and Cdt1 interaction inhibitors

FDA grants priority review to Janssen's apalutamide NDA

An2H Discovery patents parkin modulators

Biohaven begins enrolling patients in phase II/III study of trigriluzole

Millendo Therapeutics acquires Alize Pharma

FDA approves ertugliflozin and combination therapies for type 2 diabetes

BAN-2401 does not meet criteria for success in phase II Alzheimer's study

BioLineRx begins phase III GENESIS trial

Ironwood Pharmaceuticals begins phase II study of IW-1701 in sickle cell disease

Celgene updates findings from phase III study of Revlimid plus rituximab in follicular lymphoma

Avelumab in combination with axitinib awarded FDA breakthrough therapy designation

FDA approves Giapreza to increase blood pressure in patients with septic or other distributive shock

Ionis Pharmaceuticals commences phase I trial of orally delivered antisense drug

FDA gives RMAT designation to Mesoblast's MPC therapy in heart failure

Roche to acquire Ignyta

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...